Business Description
Imagion Biosystems is an Australian medical imaging company founded in 2016 and headquartered in Melbourne. It uses tiny, body-safe magnetic particles to detect cancer, with its lead product MagSense currently in Phase 2 clinical testing for HER2-positive breast cancer, alongside early-stage programs targeting prostate and ovarian cancer. The company also works with Wayne State University to refine MRI techniques that support its imaging technology.
